Suppr超能文献

比较心脏生物标志物在接受心脏导管检查的患者对比剂相关急性肾损伤风险评估中的作用:一项多中心回顾性研究。

Comparison of cardiac biomarkers on risk assessment of contrast-associated acute kidney injury in patients undergoing cardiac catheterization: A multicenter retrospective study.

机构信息

Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

出版信息

Nephrology (Carlton). 2023 Nov;28(11):588-596. doi: 10.1111/nep.14233. Epub 2023 Aug 24.

Abstract

AIM

Cardiac biomarkers' predictive value of contrast-associated acute kidney injury (CA-AKI) remains unclear. We analysed whether creatine kinase isoenzyme-MB (CKMB), cardiac troponin I (cTnI) and preoperative N-terminal pro-brain natriuretic peptide (NT-proBNP) are tied to CA-AKI patients undergoing cardiac catheterization.

METHODS

In the multi-center study, we included 3553 people underwent cardiac catheterization for analysis. CA-AKI was defined as the absolute increase of over 0.3 mg/dL or an increase of more than 50% compared with the baseline serum creatinine within 48 hours following cardiac catheterization. Logistic regression model and receiver operating characteristic (ROC) curves were used to examine the association between cardiac biomarkers and CA-AKI and the efficacy of Mehran risk score (MRS) model on CA-AKI prediction with and without cardiac biomarkers.

RESULTS

Among 3553 people, 200 people eventually developed CA-AKI. The logistic regression model showed that log CKMB (odds ratio (OR): 1.97, 95%CI:1.51-2.57, p < .001), cTnI (OR: 1.03, 95%CI: 1.02-1.04, p < .001) and log NT-proBNP (OR: 3.19, 95%CI: 2.46-4.17, p < .001) were independent predictors of CA-AKI. The ROC curve demonstrated that area under the curve (AUC) of MRS was 0.733. CKMB, cTnI and NT-proBNP all significantly improved the AUC value in combination with MRS model. (NT-proBNP: 0.798, p < .001; CKMB: 0.758, p = .003; cTnI: 0.755, p = .002), among which the NT-proBNP had the best predictive efficacy improvement.

CONCLUSION

Cardiac biomarkers of CKMB, cTnI and NT-proBNP are all independently associated with CA-AKI among patients undergoing cardiac catheterization while NT-proBNP remains the best indicator. Adding CKMB, cTnI and NT-proBNP to MRS improved the prognostic efficacy and may be considered effective tools to predict the risk of CA-AKI in clinical practice.

摘要

目的

肌酸激酶同工酶-MB(CKMB)、心肌肌钙蛋白 I(cTnI)和术前 N 端脑利钠肽前体(NT-proBNP)与接受心脏导管检查的对比剂相关急性肾损伤(CA-AKI)患者的关系尚不清楚。我们分析了这些心脏生物标志物是否与接受心脏导管检查的患者的 CA-AKI 相关。

方法

在这项多中心研究中,我们纳入了 3553 名接受心脏导管检查的患者进行分析。CA-AKI 的定义为心脏导管检查后 48 小时内血清肌酐绝对值增加超过 0.3mg/dL 或与基线相比增加超过 50%。采用 logistic 回归模型和受试者工作特征(ROC)曲线,评估心脏生物标志物与 CA-AKI 之间的关系,以及 Mehran 风险评分(MRS)模型预测 CA-AKI 的效能,同时评估有无心脏生物标志物。

结果

在 3553 名患者中,200 名最终发生了 CA-AKI。logistic 回归模型显示,log CKMB(比值比(OR):1.97,95%置信区间(CI):1.51-2.57,p<0.001)、cTnI(OR:1.03,95%CI:1.02-1.04,p<0.001)和 log NT-proBNP(OR:3.19,95%CI:2.46-4.17,p<0.001)是 CA-AKI 的独立预测因素。ROC 曲线显示,MRS 的曲线下面积(AUC)为 0.733。CKMB、cTnI 和 NT-proBNP 与 MRS 模型联合使用均显著提高 AUC 值。(NT-proBNP:0.798,p<0.001;CKMB:0.758,p=0.003;cTnI:0.755,p=0.002),其中 NT-proBNP 的预测效果改善最佳。

结论

在接受心脏导管检查的患者中,CKMB、cTnI 和 NT-proBNP 等心脏生物标志物均与 CA-AKI 独立相关,而 NT-proBNP 仍是最佳指标。将 CKMB、cTnI 和 NT-proBNP 加入 MRS 可提高预测效能,可能是预测临床实践中 CA-AKI 风险的有效工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验